Superficial Punctate Keratitis Treatment Market
Superficial Punctate Keratitis Treatment Market Size, Share & Trends Analysis by Product Type (Drops, Ointments, and Others (Bandages)), By Route Of Administration (Oral and Topical), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) Forecast Period (2025-2035)
Industry Overview
Superficial punctate keratitis (SPK) treatment market was valued at $1,470 million in 2024 and is projected to reach $3,850 billion by 2035, growing at a CAGR of 9.2% from 2025 to 2035. Superficial Punctate Keratitis (SPK) treatment aims to relieve symptoms, heal the corneal surface, along with addressing root causes. The rising prevalence of eye disorders globally is expected to propel the growth of the market during the forecast period. The rising eye disorders are associated with ageing populations, as a large portion of the population is ageing and experiencing age-related eye conditions such as dry eye syndrome, corneal damage, and others. FOR instance, according to the Moran Core – Clinical Ophthalmology Resource for Education, the number of older adults is expected to increase to 78.3 million by 2040 and 82 million by 2050. The growing elderly population heightens the risk of superficial punctate keratitis, which will further impact the market growth positively. Additionally, the National Institutes of Health (NIH) estimated that by 2050, there will be 50.2 million people in the US alone who will have visually significant cataracts.
Market Dynamics
Increasing Screen Time and Digital Device Usage is Contributing to a Higher Incidence of SPK
The incidence of superficial punctate keratitis is growing, associated with the increasing screen time and excessive use of digital devices. The continuous exposure to devices such as smartphones, computers, and tablets leads to decreased blinking rates and digital eye strain. This is causing dryness, irritation, and microdamage to the corneal surface. For instance, according to the Kutest Kids, in 2024, the global average screen time stands at 6 hours and 40 minutes per day. Additionally, this increase reflects a growing trend over the years, particularly among teenagers.
Growing Awareness of Eye Health & Early Diagnosis is Boosting Treatment Adoption
The increasing public education campaigns, digital health initiatives, and routine eye screening programs are making people more conscious of ocular health and the risk associated with untreated eye disorders. The growing awareness of eye health checkups and the importance of early diagnosis is further boosting the growth of the market during the forecast period. For instance, in May 2025, according to the National Institute of Ophthalmology (NIO), a survey conducted with 3,000 patients found 37% of them were suffering from dry eye symptoms caused by prolonged exposure to digital screens. Thus, patients will be more likely to seek medical consultation, further creating demand in the market.
Market Segmentation
- Based on the product type, the market is segmented into drops, ointments, and others. The other segment includes bandages.
- Based on the route of administration, the market is segmented into oral and topical.
- Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
Drops Segment to Lead the Market with the Largest Share
The market for drops is increasing owing to the exceptional properties of drops, such as user-friendly application, ease of use independently, protective properties, and more. The drops support the shield of the cornea to avoid more irritation, along with healing. The benefits associated with the drops are expected to increase the adoption rate, propelling market growth. For instance, in December 2024, Price Vision Group announced that the company would use the new FDA-approved drug, Oxervate (cenegermin). Oxervate drug is the only treatment with complete corneal healing potential in just 8 weeks of eye drop use for neurotrophic keratitis patients.
Global Superficial Punctate Keratitis Treatment Market Share by Product Type, 2024 (%)
Topical: A Key Segment in Market Growth
Among routes of administration, topical is expected to be a key segment in the market growth. The topical route of administration directly supplies the drug to the cornea, making it the preferred route for treating superficial punctate keratitis. Topical ensures faster symptom relief and higher local drug concentration compared to oral therapies.
Regional Outlook
The global superficial punctate keratitis treatment market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
North America to Lead Superficial Punctate Keratitis Treatment Market
The North American region is expected to lead the superficial punctate keratitis treatment market share during the forecast period. The factors such as high healthcare spending, advanced ophthalmic infrastructure, widespread awareness of eye health, and strong adoption of innovative SPK treatments are boosting the market growth. For instance, the National Eye Institute (NEI) created the National Eye Health Education Program in the US to educate both professionals and the public about the importance of eye health. It works closely with professionals and the public to raise awareness in their communities.
Asia-Pacific to Provide a Substantial Growth Rate
The Asia-Pacific region is expected to provide a substantial growth rate during the forecast period. The growth in the region is majorly propelled due to the presence of a large and ageing population, rising digital device usage, increasing prevalence of eye disorders, and expanding healthcare infrastructure in countries such as China, India, and Japan. Additionally, rapid urbanization and growing awareness about eye health will further fuel market growth in this region. For instance, in 2024, a study published in Scientific Reports 2024 highlighted that increased digital screen time is associated with a higher risk of myopia. Additionally, each hour of daily screen time raises the risk by 21%.
Market Players Outlook
The major companies operating in the global superficial punctate keratitis treatment market include AbbVie (Allergan), Johnson & Johnson Vision, Bausch + Lomb, Santen Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Alcon Vision LLC, Pfizer Inc., Merck KGaA, and Dompé US, Inc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisitions strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In December 2024, VisiRose introduced Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT). RBPDAT is a non-invasive Investigational treatment for infectious keratitis and other serious eye infections. The therapy was developed by the University of Miami Miller School of Medicine's Bascom Palmer Eye Institute (BPEI).
The Report Covers
- Market value data analysis for 2024 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global superficial punctate keratitis treatment Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Superficial Punctate Keratitis Treatment Market Sales Analysis – Product Type | Route Of Administration | Distribution Channel ($ Million)
- Superficial Punctate Keratitis Treatment Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Superficial Punctate Keratitis Treatment Industry Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Superficial Punctate Keratitis Treatment Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Superficial Punctate Keratitis Treatment Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Superficial Punctate Keratitis Treatment Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Superficial Punctate Keratitis Treatment Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Superficial Punctate Keratitis Treatment Market Revenue and Share by Manufacturers
- Superficial Punctate Keratitis Treatment Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- AbbVie
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Alcon Vision LLC
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Bausch + Lomb Corp.
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Johnson & Johnson Vision
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Santen Pharmaceutical Co., Ltd.
- Overview
- Product Portfolio
- Financial Analysis (Subject to Data Availability)
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- AbbVie
- Key Company Analysis
- Global Superficial Punctate Keratitis Treatment Market Sales Analysis by Product Type ($ Million)
- Drops
- Ointments
- Others (Bandages)
- Global Superficial Punctate Keratitis Treatment Market Sales Analysis by Route Of Administration ($ Million)
- Oral
- Topical
- Global Superficial Punctate Keratitis Treatment Market Sales Analysis by Distribution Channel ($ Million)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Analysis
- North American Superficial Punctate Keratitis Treatment Market Sales Analysis – Product Type | Route Of Administration | Distribution Channel | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Superficial Punctate Keratitis Treatment Market Sales Analysis – Product Type | Route Of Administration | Distribution Channel | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Superficial Punctate Keratitis Treatment Market Sales Analysis – Product Type | Route Of Administration | Distribution Channel | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Others)
- Rest of Asia-Pacific
- Rest of the World Superficial Punctate Keratitis Treatment Market Sales Analysis – Product Type | Route Of Administration | Distribution Channel | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- AbbVie (Allergan)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Alcon Vision LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Altova Healthcare Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bausch + Lomb Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cayman Chemical Co.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Reddy's Laboratories Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Dompé US, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Grand Pharma Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Harrow Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Johnson & Johnson Vision
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Matinas BioPharma Holdings, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck KGaA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Neuroptika, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ROHTO Pharmaceutical Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pfizer Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Prestige Consumer Healthcare Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shenzhen Contacare Technology Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sun Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Santen Pharmaceutical Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Taro Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Xellia ApS
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AbbVie (Allergan)
1. Global Superficial Punctate Keratitis Treatment Market Research And Analysis By Product Type, 2024-2035 ($ Million)
2. Global Superficial Punctate Keratitis Treatment By Drops Market Research And Analysis By Region, 2024-2035 ($ Million)
3. Global Superficial Punctate Keratitis Treatment By Ointments Market Research And Analysis By Region, 2024-2035 ($ Million)
4. Global Superficial Punctate Keratitis Treatment By Others Product Type Market Research And Analysis By Region, 2024-2035 ($ Million)
5. Global Superficial Punctate Keratitis Treatment Market Research And Analysis By Route Of Administration, 2024-2035 ($ Million)
6. Global Oral Superficial Punctate Keratitis Treatment Market Research And Analysis By Region, 2024-2035 ($ Million)
7. Global Topical Superficial Punctate Keratitis Treatment Market Research And Analysis By Region, 2024-2035 ($ Million)
8. Global Superficial Punctate Keratitis Treatment Market Research And Analysis By Distribution Channel, 2024-2035 ($ Million)
9. Global Superficial Punctate Keratitis Treatment For Hospital Pharmacies Market Research And Analysis By Region, 2024-2035 ($ Million)
10. Global Superficial Punctate Keratitis Treatment For Retail Pharmacies Market Research And Analysis By Region, 2024-2035 ($ Million)
11. Global Superficial Punctate Keratitis Treatment For Online Pharmacies Market Research And Analysis By Region, 2024-2035 ($ Million)
12. Global Superficial Punctate Keratitis Treatment Market Research And Analysis By Geography, 2024-2035 ($ Million)
13. North American Superficial Punctate Keratitis Treatment Market Research And Analysis By Country, 2024-2035 ($ Million)
14. North American Superficial Punctate Keratitis Treatment Market Research And Analysis By Product, 2024-2035 ($ Million)
15. North American Superficial Punctate Keratitis Treatment Market Research And Analysis By Route Of Administration, 2024-2035 ($ Million)
16. North American Superficial Punctate Keratitis Treatment Market Research And Analysis By Distribution Channel, 2024-2035 ($ Million)
17. European Superficial Punctate Keratitis Treatment Market Research And Analysis By Country, 2024-2035 ($ Million)
18. European Superficial Punctate Keratitis Treatment Market Research And Analysis By Product, 2024-2035 ($ Million)
19. European Superficial Punctate Keratitis Treatment Market Research And Analysis By Route Of Administration, 2024-2035 ($ Million)
20. European Superficial Punctate Keratitis Treatment Market Research And Analysis By Distribution Channel, 2024-2035 ($ Million)
21. Asia-Pacific Superficial Punctate Keratitis Treatment Market Research And Analysis By Country, 2024-2035 ($ Million)
22. Asia-Pacific Superficial Punctate Keratitis Treatment Market Research And Analysis By Product, 2024-2035 ($ Million)
23. Asia-Pacific Superficial Punctate Keratitis Treatment Market Research And Analysis By Route Of Administration, 2024-2035 ($ Million)
24. Asia-Pacific Superficial Punctate Keratitis Treatment Market Research And Analysis By Distribution Channel, 2024-2035 ($ Million)
25. Rest Of The World Superficial Punctate Keratitis Treatment Market Research And Analysis By Country, 2024-2035 ($ Million)
26. Rest Of The World Superficial Punctate Keratitis Treatment Market Research And Analysis By Product, 2024-2035 ($ Million)
27. Rest Of The World Superficial Punctate Keratitis Treatment Market Research And Analysis By Route Of Administration, 2024-2035 ($ Million)
28. Rest Of The World Superficial Punctate Keratitis Treatment Market Research And Analysis By Distribution Channel, 2024-2035 ($ Million)
1. Global Superficial Punctate Keratitis Treatment Market Share By Product, 2024 Vs 2035 (%)
2. Global Superficial Punctate Keratitis Treatment By Drops Market Share By Region, 2024 Vs 2035 (%)
3. Global Superficial Punctate Keratitis Treatment By Ointments Market Share By Region, 2024 Vs 2035 (%)
4. Global Superficial Punctate Keratitis Treatment By Others Market Share By Region, 2024 Vs 2035 (%)
5. Global Superficial Punctate Keratitis Treatment Market Share By Route Of Administration, 2024 Vs 2035 (%)
6. Global Oral Superficial Punctate Keratitis Treatment Market Share By Region, 2024 Vs 2035 (%)
7. Global Topical Superficial Punctate Keratitis Treatment Market Share By Region, 2024 Vs 2035 (%)
8. Global Superficial Punctate Keratitis Treatment Market Share By Distribution Channel, 2024 Vs 2035 (%)
9. Global Superficial Punctate Keratitis Treatment For Hospital Pharmacies Market Share By Region, 2024 Vs 2035 (%)
10. Global Superficial Punctate Keratitis Treatment For Retail Pharmacies Market Share By Region, 2024 Vs 2035 (%)
11. Global Superficial Punctate Keratitis Treatment For Online Pharmacies Market Share By Region, 2024 Vs 2035 (%)
12. Global Superficial Punctate Keratitis Treatment Market Share By Region, 2024 Vs 2035 (%)
13. US Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
14. Canada Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
15. UK Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
16. France Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
17. Germany Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
18. Italy Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
19. Spain Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
20. Russia Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
21. Rest Of Europe Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
22. India Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
23. China Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
24. Japan Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
25. South Korea Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
26. Asean Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
27. Australia And New Zealand Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
28. Rest Of Asia-Pacific Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
29. Latin America Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
30. Middle East And Africa Superficial Punctate Keratitis Treatment Market Size, 2024-2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Superficial Punctate Keratitis Treatment market in 2024 is estimated to be around $1,470 million.
North America holds the largest share in the Superficial Punctate Keratitis Treatment market.
Leading players in the Superficial Punctate Keratitis Treatment market include AbbVie (Allergan), Johnson & Johnson Vision, Bausch + Lomb, Santen Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Alcon Vision LLC, Pfizer Inc., Merck KGaA, and
Superficial Punctate Keratitis Treatment market is expected to grow at a CAGR of 9.2% from 2025 to 2035.
The solar container market is driven by rising off-grid energy needs, growing renewable adoption, and increasing focus on sustainable mobile power solutions.
